Unity Biotechnology’s (UBX) “Buy” Rating Reiterated at Chardan Capital
Chardan Capital restated their buy rating on shares of Unity Biotechnology (NASDAQ:UBX – Free Report) in a report issued on Wednesday,Benzinga reports. The brokerage currently has a $4.00 target price on the stock. Separately, HC Wainwright reaffirmed a “buy” rating and set a $4.00 target price on shares of Unity Biotechnology in a research note […]
Chardan Capital restated their buy rating on shares of Unity Biotechnology (NASDAQ:UBX – Free Report) in a report issued on Wednesday,Benzinga reports. The brokerage currently has a $4.00 target price on the stock. Separately, HC Wainwright reaffirmed a “buy” rating and set a $4.00 target price on shares of Unity Biotechnology in a research note […]
